Bacterial Pathogen Profiles and Antibiotic Resistance in Pediatric Leukemia Patients: Insights for Optimizing
Cristina Elena Singer1, Alin Iulian Silviu Popescu2, Renata Maria Văruț3
1Department of Mother and Baby, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Insights
Pediatric leukemia patients face serious bacterial infections, with MRSA being common. Understanding antibiotic resistance is crucial for effective, tailored treatments and improving survival rates in these vulnerable children.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Microbiology
Background:
- Pediatric leukemia patients are susceptible to bacterial infections due to compromised immune systems.
- Chronic pathology in these children can influence the types of pathogens encountered and their resistance patterns.
Purpose of the Study:
- To investigate the bacterial etiology and antibiotic resistance profiles in children with leukemia.
- To assess the impact of these factors on treatment efficacy and patient outcomes.
Main Methods:
- Analysis of 30 pediatric leukemia cases (ages 1-16).
- Identification of bacterial pathogens, including Gram-positive and Gram-negative species.
- Review of antibiotic resistance patterns and treatment regimens.
Main Results:
- Common pathogens identified include methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA).
- Other prevalent bacteria included Klebsiella spp. and Staphylococcus epidermidis.
- Intensive antibiotic regimens (linezolid, vancomycin, ertapenem) showed limited resistance.
Conclusions:
- Understanding specific bacterial resistance patterns is vital for guiding effective treatment strategies in pediatric leukemia patients.
- Tailored therapies based on resistance profiles can improve survival rates for these vulnerable individuals.
- Addressing multidrug-resistant bacterial infections in conjunction with pediatric leukemia is essential for enhancing therapeutic approaches.
Abstract:
Background: This study investigates bacterial etiology and antibiotic resistance in pediatric leukemia patients to determine the impact of chronic pathology on treatment efficacy. Methods: Thirty cases of children aged 1-16 years (18 boys, 12 girls) were analyzed, identifying 13 pathogens, including 8 Gram-positive and 5 Gram-negative bacteria. Results: Among the patients, 11 girls presented with acute lymphoblastic leukemia (ALL) type B, while one boy and one girl had acute myeloid leukemia, and, as for boys, three had ALL type T and two had pre-B ALL. The most common pathogens were methicillin-resistant Staphylococcus aureus (MRSA, 11 patients), methicillin-sensitive Staphylococcus aureus (MSSA, 6 patients), Klebsiella spp., and Staphylococcus epidermidis. Due to the patients' compromised health, most required intensive care and strong antibiotic regimens, including linezolid, vancomycin, and ertapenem, which showed limited resistance. Conclusions: These findings highlight the critical importance of understanding bacterial resistance patterns to guide effective treatments in vulnerable populations. Knowing specific resistance profiles can be lifesaving, allowing for tailored therapies that improve survival rates in children with leukemia facing serious bacterial infections. Focusing on the dual aspects of pediatric patients and multidrug-resistant bacterial infections, this study aims to highlight the importance of addressing these factors together to enhance therapeutic approaches in vulnerable populations.
Related Concept Videos
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:33Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...